EMAIL THIS PAGE TO A FRIEND

Journal of medicinal chemistry

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.


PMID 2552117

Abstract

A novel class of low molecular weight protein tyrosine kinase inhibitors is described. These compounds constitute a systematic series of molecules with a progressive increase in affinity toward the substrate site of the EGF receptor kinase domain. These competitive inhibitors also effectively block the EGF-dependent autophosphorylation of the receptor. The potent EGF receptor kinase blockers examined were found to competitively inhibit the homologous insulin receptor kinase at 10(2)-10(3) higher inhibitor concentrations in spite of the significant homology between these protein tyrosine kinases. These results demonstrate the ability to synthesize selective tyrosine kinase inhibitors. The most potent EGF receptor kinase inhibitors also inhibit the EGF-dependent proliferation of A431/clone 15 cells with little or no effect on EGF independent cell growth. These results demonstrate the potential use of protein tyrosine kinase inhibitors as selective antiproliferative agents for proliferative diseases caused by the hyperactivity of protein tyrosine kinases. We have suggested the name "tyrphostins" for this class of antiproliferative compounds which act as protein tyrosine kinase blockers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T7040
Tyrphostin 1, ≥98%
C11H8N2O
T7165
Tyrphostin 23, ≥98%
C10H6N2O2
T7665
Tyrphostin 51, ≥98%
C13H8N4O3